Oral News and Research

RSS

Diabetes over-treatment could be more dangerous for elderly find study

Diabetes, especially type 2 diabetes mellitus affects a large population across the globe. Treatment usually comprises of the use of oral drugs that could reduce the blood sugar and keep the glycosylated hemoglobin levels or HbA1c less than 7 percent.

19 Feb 2020

Study reveals how overexposure to fluoride causes defects in tooth enamel

Exposing teeth to excessive fluoride alters calcium signaling, mitochondrial function, and gene expression in the cells forming tooth enamel- a novel explanation for how dental fluorosis, a condition caused by overexposure to fluoride during childhood, arises.

18 Feb 2020

Salivary uric acid found to be a good predictor of body fat percentage in adolescents

In addition to helping us chew and swallow, keeping the mouth moist and protecting us against germs, saliva can also be used for early detection of the risk of developing diseases associated with surplus body fat.

18 Feb 2020

Smart athletic mouthguard licensed from University of Maryland, Baltimore

Technology for a smart mouthguard from the University of Maryland, Baltimore has been licensed by University of Maryland School of Dentistry alumnus Michael Wright, DDS, MS, into his new startup company, The WrightGuard Innovation Corporation.

17 Feb 2020

Rutgers surgeon looks at link between WWI facial trauma and modern plastic surgery

Shahid Aziz has spent hours poring over the case histories of World War I soldiers who returned home with disfiguring facial injuries.

17 Feb 2020

Advancing a protein drug in lettuce leaves to treat pulmonary arterial hypertension

In pulmonary arterial hypertension, high blood pressure in the lungs' arteries causes the heart to work extra hard to pump blood to the lungs and around the rest of the body.

16 Feb 2020

Scientists create world’s first model of pituitary disease using human iPS cells

Researchers at Kobe University's Graduate School of Medicine have developed the world's first congenital pituitary hypoplasia model using patient-derived iPS cells.

14 Feb 2020

Legionella Conference 2020 focuses on prevention of health care-associated waterborne diseases

Discussions at Legionella Conference 2020: Prevention of Disease and Injury From Waterborne Pathogens in Health Care will focus on hazards related to medical devices, cleaning and disinfection in sterile settings and water quality requirements in hospitals and health care facilities.

14 Feb 2020

FDA approves first oral immunotherapy treatment for peanut allergy in children, teens

The University of Chicago Medicine was part of a landmark clinical trial that led to approval by the U.S. Food and Drug Administration of the first oral immunotherapy treatment for peanut allergy in children and teens.

13 Feb 2020

Romantic partner’s scent can improve sleep, study suggests

The scent of a romantic partner can improve sleep, suggests new psychology research from the University of British Columbia.

13 Feb 2020

Discovery of compound that reverses the fertility clock

The reproductive years of a woman are at their peak before the age of 30. Beyond that, fertility starts to decline, and by the age of 40, fertility potential is about half the level it was before 30 years old. Many women experience fertility issues, but now a new study on mice may help reverse the clock on eggs, offering new fertility hope to older women.

13 Feb 2020

Living in greener neighborhoods may delay onset of menopause

Living near green spaces is associated with a wide variety of benefits, including a lower risk of obesity, improved attention capacity in children and slower physical decline in old age.

13 Feb 2020

Scientists report promising activity of novel targeted drug in patients with advanced kidney cancer

Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease.

13 Feb 2020

P53-deficient oral cancers recruit and reprogram nerves to fuel tumor growth

Loss of an important tumor-suppressing gene allows head and neck cancer to spin off signals to nearby nerves, changing their function and recruiting them to the tumor, where they fuel growth and cancer progression, researchers from The University of Texas MD Anderson Cancer Center report in the journal Nature today.

13 Feb 2020

Gum disease linked to stroke

A pair of new studies has revealed that gum diseases could be associated with a heightened risk of strokes and atherosclerosis of hardening of the arterial walls. The results of this new research are to be presented at the American Stroke Association's International Stroke Conference 2020 between 19th and 21st of February 2020 in Los Angeles.

12 Feb 2020

UQ researchers reverse reproductive aging process in mice

Researchers have lifted fertility rates in older female mice with small doses of a metabolic compound that reverses the aging process in eggs, offering hope for some women struggling to conceive.

12 Feb 2020

Recent progress in TB diagnostics and prevention approaches offers hope for future

In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.

11 Feb 2020

Microbiome can predict a person's chronological age

Our microbiomes - the complex communities of microbes that live in, on and around us - are influenced by our diets, habits, environments and genes, and are known to change with age.

11 Feb 2020

Young sexual minority men do not fully understand their risk for HPV infection

Young sexual minority men -- including those who are gay, bisexual, queer or straight-identified men who have sex with men -- do not fully understand their risk for human papillomavirus due to a lack of information from health care providers, according to Rutgers researchers.

11 Feb 2020

Braincool completes patient recruitment to study Cooral System for prevention of Oral Mucositis

BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.

11 Feb 2020

Oral News and Research

Diabetes over-treatment could be more dangerous for elderly find study

Study reveals how overexposure to fluoride causes defects in tooth enamel

Salivary uric acid found to be a good predictor of body fat percentage in adolescents

Smart athletic mouthguard licensed from University of Maryland, Baltimore

Rutgers surgeon looks at link between WWI facial trauma and modern plastic surgery

Advancing a protein drug in lettuce leaves to treat pulmonary arterial hypertension

Scientists create world’s first model of pituitary disease using human iPS cells

Legionella Conference 2020 focuses on prevention of health care-associated waterborne diseases

FDA approves first oral immunotherapy treatment for peanut allergy in children, teens

Romantic partner’s scent can improve sleep, study suggests

Discovery of compound that reverses the fertility clock

Living in greener neighborhoods may delay onset of menopause

Scientists report promising activity of novel targeted drug in patients with advanced kidney cancer

P53-deficient oral cancers recruit and reprogram nerves to fuel tumor growth

Gum disease linked to stroke

UQ researchers reverse reproductive aging process in mice

Recent progress in TB diagnostics and prevention approaches offers hope for future

Microbiome can predict a person's chronological age

Young sexual minority men do not fully understand their risk for HPV infection

Braincool completes patient recruitment to study Cooral System for prevention of Oral Mucositis

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News